Pub Date : 2019-11-25DOI: 10.3760/CMA.J.ISSN.2095-1477.2019.11.005
Xia Huang, Jun Yuan, Zhi-gang Zhao
Objective To evaluate the clinical efficacy of anterior chamber gas injection for the treatment of detachment of corneal Descemet’s membrane after cataract surgery. Methods The data of 31 eyes of 31 patients with corneal Descemet’s membrane detachment after phacoemulsification in this hospital from Nov. 2015 to Nov. 2018 were retrospectively analyzed.Anterior chamber gas injections were performed at 1 day after surgery. The patients were followed up for 3 months. Results The corneal Descemet’s membranes restored well after surgery in 29 patients(93.55%). One patient(3.23%) with local corneal Descemet’s membrane detachment restored, after using regional anti-inflammatory and hypertonic eye drips. One patient (3.23%) with partial detachment, anterior chamber gas injection was performed again. All these 31 patients had visual acuity improvements after surgery(t=6.926, P=0.000). Conclusion Anterior chamber gas injection in early stage is a safe and effective method for corneal Descemet’s membrane detachment after cataract surgery. Key words: Detachment, membrane, Descemet’s, corneal; Surgery, cataract; Injection, gas, anterior chamber
{"title":"Anterior chamber gas injection for the treatment of detachment of corneal Descemet’s membrane after cataract surgery","authors":"Xia Huang, Jun Yuan, Zhi-gang Zhao","doi":"10.3760/CMA.J.ISSN.2095-1477.2019.11.005","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.2095-1477.2019.11.005","url":null,"abstract":"Objective \u0000To evaluate the clinical efficacy of anterior chamber gas injection for the treatment of detachment of corneal Descemet’s membrane after cataract surgery. \u0000 \u0000 \u0000Methods \u0000The data of 31 eyes of 31 patients with corneal Descemet’s membrane detachment after phacoemulsification in this hospital from Nov. 2015 to Nov. 2018 were retrospectively analyzed.Anterior chamber gas injections were performed at 1 day after surgery. The patients were followed up for 3 months. \u0000 \u0000 \u0000Results \u0000The corneal Descemet’s membranes restored well after surgery in 29 patients(93.55%). One patient(3.23%) with local corneal Descemet’s membrane detachment restored, after using regional anti-inflammatory and hypertonic eye drips. One patient (3.23%) with partial detachment, anterior chamber gas injection was performed again. All these 31 patients had visual acuity improvements after surgery(t=6.926, P=0.000). \u0000 \u0000 \u0000Conclusion \u0000Anterior chamber gas injection in early stage is a safe and effective method for corneal Descemet’s membrane detachment after cataract surgery. \u0000 \u0000 \u0000Key words: \u0000Detachment, membrane, Descemet’s, corneal; Surgery, cataract; Injection, gas, anterior chamber","PeriodicalId":10126,"journal":{"name":"Chinese Journal of Ocular Trauma and Occupational Eye Disease","volume":"59 1","pages":"822-825"},"PeriodicalIF":0.0,"publicationDate":"2019-11-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73368769","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-11-25DOI: 10.3760/CMA.J.ISSN.2095-1477.2019.11.003
Xiao-Hong Zhu, Wen-jie Liu, Jun-hong Zhao
Objective To analyze the distribution and related factors of the spherical aberration in patients with primary angle-closure glaucoma and cataract. Methods Retrospective series of case study. The data of 154 eyes of 120 patients of primary angle-closure glaucoma with cataract from Nov. 2018 to Mar. 2019 in this hospital were analyzed. Pentacam HR anterior segment analyzer (Oculus, Germany) was used to measure and analyse datas. Results The average age of patients was (68.00±9.95) years, ranged from 33 to 85 years. The average spherical aberration was (0.35±0.16) μm, ranged from -0.35 μm to 0.76 μm. A positive correlation was found between spherical aberration and age(r=0.287, P=0.000), spherical aberration and mean corneal refractive power(r= 0.170, P=0.035). A negative correlation was found between spherical aberration and corneal refractive power of posterior surface(r=-0.164, P=0.042). There were no correlation between spherical aberration and corneal diameter, corneal thickness, corneal volume and axis length(r=-0.034, -0.149, -0.126, -0.123, P=0.681, 0.066, 0.119, 0.134). With residual spherical aberration(0.1±0.05)μm as the target, 90 eyes (58.4%) were corrected by different aspheric IOLs(0, -0.20 μm, -0.27 μm). Conclusion Corneal spherical aberration in patients with primary angle-closure glaucoma and cataract is larger than that reported in other populations(+ 0.27 μm), and with larger fluctuation range. A suitable IOL should be selected according to the preoperative comprehensive evaluation of personalized spherical aberrations, pupil, visual field and the injury of the optic nerve. Key words: Glaucoma; Cataract; Aberration, spheric, corneal; Lens, intraocular, aspheric
{"title":"Analysis of the corneal spherical aberration in patients with primary angle-closure glaucoma with cataract","authors":"Xiao-Hong Zhu, Wen-jie Liu, Jun-hong Zhao","doi":"10.3760/CMA.J.ISSN.2095-1477.2019.11.003","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.2095-1477.2019.11.003","url":null,"abstract":"Objective \u0000To analyze the distribution and related factors of the spherical aberration in patients with primary angle-closure glaucoma and cataract. \u0000 \u0000 \u0000Methods \u0000Retrospective series of case study. The data of 154 eyes of 120 patients of primary angle-closure glaucoma with cataract from Nov. 2018 to Mar. 2019 in this hospital were analyzed. Pentacam HR anterior segment analyzer (Oculus, Germany) was used to measure and analyse datas. \u0000 \u0000 \u0000Results \u0000The average age of patients was (68.00±9.95) years, ranged from 33 to 85 years. The average spherical aberration was (0.35±0.16) μm, ranged from -0.35 μm to 0.76 μm. A positive correlation was found between spherical aberration and age(r=0.287, P=0.000), spherical aberration and mean corneal refractive power(r= 0.170, P=0.035). A negative correlation was found between spherical aberration and corneal refractive power of posterior surface(r=-0.164, P=0.042). There were no correlation between spherical aberration and corneal diameter, corneal thickness, corneal volume and axis length(r=-0.034, -0.149, -0.126, -0.123, P=0.681, 0.066, 0.119, 0.134). With residual spherical aberration(0.1±0.05)μm as the target, 90 eyes (58.4%) were corrected by different aspheric IOLs(0, -0.20 μm, -0.27 μm). \u0000 \u0000 \u0000Conclusion \u0000Corneal spherical aberration in patients with primary angle-closure glaucoma and cataract is larger than that reported in other populations(+ 0.27 μm), and with larger fluctuation range. A suitable IOL should be selected according to the preoperative comprehensive evaluation of personalized spherical aberrations, pupil, visual field and the injury of the optic nerve. \u0000 \u0000 \u0000Key words: \u0000Glaucoma; Cataract; Aberration, spheric, corneal; Lens, intraocular, aspheric","PeriodicalId":10126,"journal":{"name":"Chinese Journal of Ocular Trauma and Occupational Eye Disease","volume":"66 1","pages":"813-817"},"PeriodicalIF":0.0,"publicationDate":"2019-11-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81197215","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-11-25DOI: 10.3760/CMA.J.ISSN.2095-1477.2019.11.010
Zhengru Huang
Objective To evaluate the efficacy of cyclophotocoagulation under operating microscopy for the treatment of refractory glaucoma. Methods The clinical data of 31 eyes of 31 cases with refractory glaucoma from Jan. 2017 to Apr. 2018 in this hospital were analyzed retrospectively. All patients underwent cyclophotocoagulation under operating microscopy via pars plana. The follow-up time was 12 months at least. Results Preoperative intraocular pressure (IOP) was (34.8±8.5) mmHg (1 mmHg=0.133 kPa). Postoperative IOP at 1 day, 7 days, 1, 6 and 12 months were (18.5±6.3) mmHg, (17.1±3.7) mmHg, (16.4±2.7) mmHg, (16.2±2.9) mmHg and (16.2±3.2) mmHg, respectively. The difference were statistically significant between before and after operation (P=0.000). The success rate of surgery at the end of follow-up was 74.2%. Postoperative ultrasonic biomicroscopy showed the complete atrophy of ciliary body in the cyclophotocoagulation sites. Conclusion Cyclophotocoagulation under operating microscopy was effective and safe for the treatment of refractory glaucoma. Key words: Glaucoma, refractory; Cyclophotocoagulation, under operating microscopy
{"title":"Cyclophotocoagulation under operating microscopy for the treatment of refractory glaucoma","authors":"Zhengru Huang","doi":"10.3760/CMA.J.ISSN.2095-1477.2019.11.010","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.2095-1477.2019.11.010","url":null,"abstract":"Objective \u0000To evaluate the efficacy of cyclophotocoagulation under operating microscopy for the treatment of refractory glaucoma. \u0000 \u0000 \u0000Methods \u0000The clinical data of 31 eyes of 31 cases with refractory glaucoma from Jan. 2017 to Apr. 2018 in this hospital were analyzed retrospectively. All patients underwent cyclophotocoagulation under operating microscopy via pars plana. The follow-up time was 12 months at least. \u0000 \u0000 \u0000Results \u0000Preoperative intraocular pressure (IOP) was (34.8±8.5) mmHg (1 mmHg=0.133 kPa). Postoperative IOP at 1 day, 7 days, 1, 6 and 12 months were (18.5±6.3) mmHg, (17.1±3.7) mmHg, (16.4±2.7) mmHg, (16.2±2.9) mmHg and (16.2±3.2) mmHg, respectively. The difference were statistically significant between before and after operation (P=0.000). The success rate of surgery at the end of follow-up was 74.2%. Postoperative ultrasonic biomicroscopy showed the complete atrophy of ciliary body in the cyclophotocoagulation sites. \u0000 \u0000 \u0000Conclusion \u0000Cyclophotocoagulation under operating microscopy was effective and safe for the treatment of refractory glaucoma. \u0000 \u0000 \u0000Key words: \u0000Glaucoma, refractory; Cyclophotocoagulation, under operating microscopy","PeriodicalId":10126,"journal":{"name":"Chinese Journal of Ocular Trauma and Occupational Eye Disease","volume":"46 1","pages":"847-852"},"PeriodicalIF":0.0,"publicationDate":"2019-11-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87050986","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-11-25DOI: 10.3760/CMA.J.ISSN.2095-1477.2019.11.002
Shuai Wang
Objective To observe the application of illuminator guided retroillumination assisted continuous circular capsulorhexis. Methods A prospective study. Thirty eyes of 30 cases with cataract with vitreous hemorrhage, with poor fundus red reflex, from Sep. 2016 to Aug. 2017 in this hospital, were enrolled. After the ophthalmic endoilluminator was inserted into the vitreous, the endoilluminator was irradiated forward from the posterior lens capsule, then continuous circular capsulorhexis was performed. Phacoemulsification and vitrectomy were carried out routinely. The followed-up time was 8-12 months. Results The continuous circular capsulorhexis and phacoemulsification were performed successfully in all 30 eyes without any posterior capsule rupture. Vitreous hemaorrhage was completely removed, and retinal diseases was properly treated. The visual acuity before operation was HM-0.04 in 27 eyes(90.00%) and 0.05 in 3 eyes(10.00%). Postoperative visual acuity of all patients were 0.05 or better. The difference of visual acuity was statistically significant between before and after operation (χ2=49.091, P=0.000). Conclusion The illuminator guided retroillumination assisted continuous circular capsulorhexis can effectively solve the difficulty of poor red light reflex for cataract patients with vitreous hemorrhage. Key words: Capsulorhexis, circular, continuous, retroillumination; Phacoemulsification, lens; Vitrectomy
{"title":"Clinical observation on retroillumination assisted continuous circular capsulorhexis","authors":"Shuai Wang","doi":"10.3760/CMA.J.ISSN.2095-1477.2019.11.002","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.2095-1477.2019.11.002","url":null,"abstract":"Objective \u0000To observe the application of illuminator guided retroillumination assisted continuous circular capsulorhexis. \u0000 \u0000 \u0000Methods \u0000A prospective study. Thirty eyes of 30 cases with cataract with vitreous hemorrhage, with poor fundus red reflex, from Sep. 2016 to Aug. 2017 in this hospital, were enrolled. After the ophthalmic endoilluminator was inserted into the vitreous, the endoilluminator was irradiated forward from the posterior lens capsule, then continuous circular capsulorhexis was performed. Phacoemulsification and vitrectomy were carried out routinely. The followed-up time was 8-12 months. \u0000 \u0000 \u0000Results \u0000The continuous circular capsulorhexis and phacoemulsification were performed successfully in all 30 eyes without any posterior capsule rupture. Vitreous hemaorrhage was completely removed, and retinal diseases was properly treated. The visual acuity before operation was HM-0.04 in 27 eyes(90.00%) and 0.05 in 3 eyes(10.00%). Postoperative visual acuity of all patients were 0.05 or better. The difference of visual acuity was statistically significant between before and after operation (χ2=49.091, P=0.000). \u0000 \u0000 \u0000Conclusion \u0000The illuminator guided retroillumination assisted continuous circular capsulorhexis can effectively solve the difficulty of poor red light reflex for cataract patients with vitreous hemorrhage. \u0000 \u0000 \u0000Key words: \u0000Capsulorhexis, circular, continuous, retroillumination; Phacoemulsification, lens; Vitrectomy","PeriodicalId":10126,"journal":{"name":"Chinese Journal of Ocular Trauma and Occupational Eye Disease","volume":"23 1","pages":"808-812"},"PeriodicalIF":0.0,"publicationDate":"2019-11-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76759506","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-11-25DOI: 10.3760/CMA.J.ISSN.2095-1477.2019.11.004
Hui Su, P. Yu, Kun-ming Wang
Objective To evaluate the efficacy of deep lamellar keratoplasty for the treatment of stromal corneal dystrophy. Methods The data of 59 eyes of 49 patients with stromal corneal dystrophy in this hospital from Jan.2012 to Dec.2018 were analyzed retrospectively.All cases were treated with deep lamellar keratoplasty.The follow-up time was 6 months-4 years.The corneal graft and the complications of intra-operation and post-operation were observed. Results The corneal graft remained clear in all cases after surgery. The best corrected visual acuity (BCVA) postoperatively was 0.3 in 8 eyes, 0.4-0.6 in 40 eyes, 0.6-0.8 in 11 eyes. Intraoperative complications included perforation of descemet’s membrane in 5 eyes, postoperative temporary elevation of intraocular pressure in 4 eyes, descemet’s membrane striae in 6 cases and recurrence of primary disease in 3 eyes. No reject reaction occurred after keratoplasty. Conclusion Deep lamellar keratoplasty is a safe and effective method for the treatment of stromal corneal dystrophy. Key words: Keratoplasty, lamellar, deep; Dystrophy, corneal, Stromal
{"title":"Efficacy of deep lamellar keratoplasty for the treatment of stromal corneal dystrophy","authors":"Hui Su, P. Yu, Kun-ming Wang","doi":"10.3760/CMA.J.ISSN.2095-1477.2019.11.004","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.2095-1477.2019.11.004","url":null,"abstract":"Objective \u0000To evaluate the efficacy of deep lamellar keratoplasty for the treatment of stromal corneal dystrophy. \u0000 \u0000 \u0000Methods \u0000The data of 59 eyes of 49 patients with stromal corneal dystrophy in this hospital from Jan.2012 to Dec.2018 were analyzed retrospectively.All cases were treated with deep lamellar keratoplasty.The follow-up time was 6 months-4 years.The corneal graft and the complications of intra-operation and post-operation were observed. \u0000 \u0000 \u0000Results \u0000The corneal graft remained clear in all cases after surgery. The best corrected visual acuity (BCVA) postoperatively was 0.3 in 8 eyes, 0.4-0.6 in 40 eyes, 0.6-0.8 in 11 eyes. Intraoperative complications included perforation of descemet’s membrane in 5 eyes, postoperative temporary elevation of intraocular pressure in 4 eyes, descemet’s membrane striae in 6 cases and recurrence of primary disease in 3 eyes. No reject reaction occurred after keratoplasty. \u0000 \u0000 \u0000Conclusion \u0000Deep lamellar keratoplasty is a safe and effective method for the treatment of stromal corneal dystrophy. \u0000 \u0000 \u0000Key words: \u0000Keratoplasty, lamellar, deep; Dystrophy, corneal, Stromal","PeriodicalId":10126,"journal":{"name":"Chinese Journal of Ocular Trauma and Occupational Eye Disease","volume":"101 1","pages":"818-821"},"PeriodicalIF":0.0,"publicationDate":"2019-11-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76795443","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-11-25DOI: 10.3760/CMA.J.ISSN.2095-1477.2019.11.015
Xiaoteng Yan, Fangfang Li, Cao Gu
Objective To evaluate the efficacy of bio-amniotic membrane transplantation combined with anterior corneal stroma puncture in the treatment of recurrent corneal epithelial erosion syndrome. Methods A prospective randomized clinical study. The data of 32 eyes of 27 cases with recurrent corneal epithelial erosion syndrome were analyzed from Jan.2015 to Sep.2018 in the Affiliated Huai’an Hospital of Xuzhou Medical University. All cases were randomly divided into two groups. There were 16 eyes of 13 cases in amniotic membrane transplantation combined with anterior corneal stroma puncture group and 16 eyes of 14 cases in anterior corneal stroma puncture group. The efficacy of operation was evaluated. Results Postoperative pain scores in both groups were significantly lower than those before operation. The difference in pain scores was statistically significant between the two groups on 1 and 3 days after operation (t1=3.693, P=0.001, t3=2.725, P=0.011). The difference in pain scores was not statistically significant between the two groups on 5 days after operation (t5=1.054, P=0.300). There was no significant difference in recurrence rate between the two groups(P=0.151). Conclusion Bio-amniotic membrane transplantation combined with anterior corneal stroma puncture can effectively treat recurrent corneal epithelial erosion syndrome, which has the advantages of low recurrence rate and high comfort after operation. Key words: Transplantation, amniotic membrane; Puncture, anterior stroma, cornea; Erosion, epithelium, cornea
{"title":"Bio-amniotic membrane transplantation combined with anterior corneal stroma puncture for the treatment of recurrent corneal epithelial erosion syndrome","authors":"Xiaoteng Yan, Fangfang Li, Cao Gu","doi":"10.3760/CMA.J.ISSN.2095-1477.2019.11.015","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.2095-1477.2019.11.015","url":null,"abstract":"Objective \u0000To evaluate the efficacy of bio-amniotic membrane transplantation combined with anterior corneal stroma puncture in the treatment of recurrent corneal epithelial erosion syndrome. \u0000 \u0000 \u0000Methods \u0000A prospective randomized clinical study. The data of 32 eyes of 27 cases with recurrent corneal epithelial erosion syndrome were analyzed from Jan.2015 to Sep.2018 in the Affiliated Huai’an Hospital of Xuzhou Medical University. All cases were randomly divided into two groups. There were 16 eyes of 13 cases in amniotic membrane transplantation combined with anterior corneal stroma puncture group and 16 eyes of 14 cases in anterior corneal stroma puncture group. The efficacy of operation was evaluated. \u0000 \u0000 \u0000Results \u0000Postoperative pain scores in both groups were significantly lower than those before operation. The difference in pain scores was statistically significant between the two groups on 1 and 3 days after operation (t1=3.693, P=0.001, t3=2.725, P=0.011). The difference in pain scores was not statistically significant between the two groups on 5 days after operation (t5=1.054, P=0.300). There was no significant difference in recurrence rate between the two groups(P=0.151). \u0000 \u0000 \u0000Conclusion \u0000Bio-amniotic membrane transplantation combined with anterior corneal stroma puncture can effectively treat recurrent corneal epithelial erosion syndrome, which has the advantages of low recurrence rate and high comfort after operation. \u0000 \u0000 \u0000Key words: \u0000Transplantation, amniotic membrane; Puncture, anterior stroma, cornea; Erosion, epithelium, cornea","PeriodicalId":10126,"journal":{"name":"Chinese Journal of Ocular Trauma and Occupational Eye Disease","volume":"135 1","pages":"872-875"},"PeriodicalIF":0.0,"publicationDate":"2019-11-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74216415","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-11-25DOI: 10.3760/CMA.J.ISSN.2095-1477.2019.11.007
Zhao Xiaojin, Zhao Hong, Ding Xiang-qi
Objective To observe the clinical efficacy of posterior chamber phakic intraocular lens (ICL)for correction of high myopia. Methods The data of 110 eyes of 55 cases with high myopia(-6.00 D--18.00 D)who received ICL implantation from Dec. 2017 to Sep. 2018 were collected and analyzed retrospectively. The patients were followed up for 3 months. The data were observed and analyzed between preoperative and postoperative. Results The differences of the average uncorrected visual acuity, best corrected visual acuity(LogMAR) and refraction were statistically significant between preoperative and 3 months postoperatively(t=14.580, 13.240, 11.770, P=0.010, 0.021, 0.013). There was significant difference of the root mean square value in the general lower-order aberrations between preoperative and 3 months postoperatively(t=-18.780, P=0.000). The differences in the general higher-order aberrations, 3-order aberrations, 4-order aberrations, and 5-order aberrations root mean square value were not statistically significant between preoperative and 3 months postoperatively(t=-1.278, 0.785, 0.351, 0.457, P=0.125, 0.412, 0.224, 0.324). The differrences of Z40, Z31, Z3-1, Z33, Z3-3 were not statistically significant between preoperative and 3 months postoperatively (t=0.654, 0.545, 0.387, 0.268, 0.578, P=0.547, 0.371, 0.241, 0.187, 0.428). Conclusion Posterior chamber phakic intraocular lens is safe, effective, predictable and stable for correction of high myopia and postoperative visual quality is good. Key words: Lens, intraocular, phakic, posterior chamber; Myopia, high; Visual quality
{"title":"Posterior chamber phakic intraocular lens for correction of high myopia","authors":"Zhao Xiaojin, Zhao Hong, Ding Xiang-qi","doi":"10.3760/CMA.J.ISSN.2095-1477.2019.11.007","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.2095-1477.2019.11.007","url":null,"abstract":"Objective \u0000To observe the clinical efficacy of posterior chamber phakic intraocular lens (ICL)for correction of high myopia. \u0000 \u0000 \u0000Methods \u0000The data of 110 eyes of 55 cases with high myopia(-6.00 D--18.00 D)who received ICL implantation from Dec. 2017 to Sep. 2018 were collected and analyzed retrospectively. The patients were followed up for 3 months. The data were observed and analyzed between preoperative and postoperative. \u0000 \u0000 \u0000Results \u0000The differences of the average uncorrected visual acuity, best corrected visual acuity(LogMAR) and refraction were statistically significant between preoperative and 3 months postoperatively(t=14.580, 13.240, 11.770, P=0.010, 0.021, 0.013). There was significant difference of the root mean square value in the general lower-order aberrations between preoperative and 3 months postoperatively(t=-18.780, P=0.000). The differences in the general higher-order aberrations, 3-order aberrations, 4-order aberrations, and 5-order aberrations root mean square value were not statistically significant between preoperative and 3 months postoperatively(t=-1.278, 0.785, 0.351, 0.457, P=0.125, 0.412, 0.224, 0.324). The differrences of Z40, Z31, Z3-1, Z33, Z3-3 were not statistically significant between preoperative and 3 months postoperatively (t=0.654, 0.545, 0.387, 0.268, 0.578, P=0.547, 0.371, 0.241, 0.187, 0.428). \u0000 \u0000 \u0000Conclusion \u0000Posterior chamber phakic intraocular lens is safe, effective, predictable and stable for correction of high myopia and postoperative visual quality is good. \u0000 \u0000 \u0000Key words: \u0000Lens, intraocular, phakic, posterior chamber; Myopia, high; Visual quality","PeriodicalId":10126,"journal":{"name":"Chinese Journal of Ocular Trauma and Occupational Eye Disease","volume":"4 1","pages":"833-837"},"PeriodicalIF":0.0,"publicationDate":"2019-11-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74384465","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-11-25DOI: 10.3760/CMA.J.ISSN.2095-1477.2019.11.001
Bo Jiang, Tao Li, Man She, Xiaoqian Yao
Objective To investigate the manifestation of dry eye and TGF-β expression in patients after ocular alkali burns. Methods This is a case-control study. Total of 33 eyes of 26 cases with alkali burns of I-IV degrees from Jan.2017 to Jun.2018 in this hospital were selected as observation group, and 10 eyes of 10 cases of normal people were selected as control group. The followed-up time was 3 months. The visual acuity, intraocular pressure, BUT, SchirmerⅠtest, lacrimal rivus height and corneal thickness were observed at 1 day, 1 and 3 months after ocular alkali burn. The protein expression of TGF-β1 and TGF-β2 were examined with western-blot analysis. Results BUT and Schirmer I test in the observation group were lower than those in the control group at 3 months after ocular alkali burn (P<0.05). The corneal thickness and the lacrimal rivus height at each time after ocular alkali burn were higher than those in the control group(P<0.05). The protein expressions of TGF-β1 and TGF-β2 were significantly negatively correlated with BUT(P=0.046, 0.036), and TGF-β2 was significantly positively correlated with corneal thickness (P=0.024). Conclusion Ocular alkali burns can cause dry eye, and the expressions of TGF-β1 and TGF-β2 in tears may be related to the occurrence of dry eye after ocular alkali burn. Key words: Burn, alkali, ocular; Dry eye; OCT; TGF-β1; TGF-β2
{"title":"Study of manifestations of dry eye and TGF-β expression after ocular alkali burn","authors":"Bo Jiang, Tao Li, Man She, Xiaoqian Yao","doi":"10.3760/CMA.J.ISSN.2095-1477.2019.11.001","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.2095-1477.2019.11.001","url":null,"abstract":"Objective \u0000To investigate the manifestation of dry eye and TGF-β expression in patients after ocular alkali burns. \u0000 \u0000 \u0000Methods \u0000This is a case-control study. Total of 33 eyes of 26 cases with alkali burns of I-IV degrees from Jan.2017 to Jun.2018 in this hospital were selected as observation group, and 10 eyes of 10 cases of normal people were selected as control group. The followed-up time was 3 months. The visual acuity, intraocular pressure, BUT, SchirmerⅠtest, lacrimal rivus height and corneal thickness were observed at 1 day, 1 and 3 months after ocular alkali burn. The protein expression of TGF-β1 and TGF-β2 were examined with western-blot analysis. \u0000 \u0000 \u0000Results \u0000BUT and Schirmer I test in the observation group were lower than those in the control group at 3 months after ocular alkali burn (P<0.05). The corneal thickness and the lacrimal rivus height at each time after ocular alkali burn were higher than those in the control group(P<0.05). The protein expressions of TGF-β1 and TGF-β2 were significantly negatively correlated with BUT(P=0.046, 0.036), and TGF-β2 was significantly positively correlated with corneal thickness (P=0.024). \u0000 \u0000 \u0000Conclusion \u0000Ocular alkali burns can cause dry eye, and the expressions of TGF-β1 and TGF-β2 in tears may be related to the occurrence of dry eye after ocular alkali burn. \u0000 \u0000 \u0000Key words: \u0000Burn, alkali, ocular; Dry eye; OCT; TGF-β1; TGF-β2","PeriodicalId":10126,"journal":{"name":"Chinese Journal of Ocular Trauma and Occupational Eye Disease","volume":"17 1","pages":"801-807"},"PeriodicalIF":0.0,"publicationDate":"2019-11-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79346886","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-11-25DOI: 10.3760/CMA.J.ISSN.2095-1477.2019.11.008
M. Yu, Wenjie Wu, D. Yan, Xinna Wu, Ting Yu
Objective To evaluate the safety and efficacy of removal of residual silicone oil droplet with posterior lens capsulotomy. Methods A retrospective study. Total 12 eyes of 12 consecutive patients with residual silicone oil droplet after silicone oil removal from Aug. 2013 to Apr. 2019 were collected in Fujian provincial hospital. There were 10 eyes received posterior lens capsulotomy combined with phacoemulsification, and 2 eyes received posterior lens capsulotomy combined with secondary intraocular lens implantation. The intra-operative complications, postoperative silicone oil droplet residual rate, best corrected visual acuity, intraocular pressure, anterior segment and fundus examination were observed. Results The patients were followed up for 1-69 months. Postoperative visual disturbance symptoms and the best corrected visual acuity were ameliorated in all patients. The visual acuity at the last follow up was 0.3 in 5 eyes (41.7%) and ≥0.5 in 3 eyes (25.0%). No postoperative complication such as increased intraocular pressure, retinal detachment or choroidal detachment occurred. The intraocular lens position were stable during the follow-up period. Conclusion It is a simple, safe and effective way to remove silicone oil droplet with posterior lens capsulotomy. Key words: Capsulotomy, posterior capsule, lens; Phacoemulsification, ultrasonic, lens; Implantation, lens, intraocular
{"title":"The efficacy of removal of residual silicone oil droplet with posterior lens capsulotomy","authors":"M. Yu, Wenjie Wu, D. Yan, Xinna Wu, Ting Yu","doi":"10.3760/CMA.J.ISSN.2095-1477.2019.11.008","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.2095-1477.2019.11.008","url":null,"abstract":"Objective \u0000To evaluate the safety and efficacy of removal of residual silicone oil droplet with posterior lens capsulotomy. \u0000 \u0000 \u0000Methods \u0000A retrospective study. Total 12 eyes of 12 consecutive patients with residual silicone oil droplet after silicone oil removal from Aug. 2013 to Apr. 2019 were collected in Fujian provincial hospital. There were 10 eyes received posterior lens capsulotomy combined with phacoemulsification, and 2 eyes received posterior lens capsulotomy combined with secondary intraocular lens implantation. The intra-operative complications, postoperative silicone oil droplet residual rate, best corrected visual acuity, intraocular pressure, anterior segment and fundus examination were observed. \u0000 \u0000 \u0000Results \u0000The patients were followed up for 1-69 months. Postoperative visual disturbance symptoms and the best corrected visual acuity were ameliorated in all patients. The visual acuity at the last follow up was 0.3 in 5 eyes (41.7%) and ≥0.5 in 3 eyes (25.0%). No postoperative complication such as increased intraocular pressure, retinal detachment or choroidal detachment occurred. The intraocular lens position were stable during the follow-up period. \u0000 \u0000 \u0000Conclusion \u0000It is a simple, safe and effective way to remove silicone oil droplet with posterior lens capsulotomy. \u0000 \u0000 \u0000Key words: \u0000Capsulotomy, posterior capsule, lens; Phacoemulsification, ultrasonic, lens; Implantation, lens, intraocular","PeriodicalId":10126,"journal":{"name":"Chinese Journal of Ocular Trauma and Occupational Eye Disease","volume":"44 1","pages":"838-841"},"PeriodicalIF":0.0,"publicationDate":"2019-11-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83491143","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Objective To observe the efficacy of intravitreal ranibizumab injection with panretinal photocoagulation for the treatment of neovascular glaucoma. Methods Total of 20 eyes of 20 cases with neovascular glaucoma in Bayannur Federation of Disabled People’s Eye Hospital from Jan. 2015 to Feb. 2018 were analyzed retrospectively. All cases were treated with intravitreal ranibizumb injection(0.5 mg/0.05 ml)and panretinal photocoagulation at 1 week after injection. Results The IOP was(19.45±8.54)mmHg(1mmHg=0.133 kPa)at 3 months after treatment, which was significantly lower than that before treatment(41.80±9.84)mmHg(P=0.000). The visual acuity was improved significantly (P=0.000). The new vessels of iris and anterior chamber angle basically disappeared. There was no serious complication or adverse reactions in all patients. Conclusion Intravitreal ranibizunmb injection combined with panretinal photocoagulation for the treatment of neovascular glaucoma can significantly reduce the IOP and improve visual function of the patients without obvious adverse reactions. Key words: Glaucoma, neovascular; Ranibizumab; Injection, intravitreal; Photocoagulation, panretinal
{"title":"Intravitreal ranibizumab injection combined with panretinal photocoagulation for the treatment of neovascular glaucoma","authors":"Yongcheng Hu, Zhike Zhang, Ping Zhang, Xudong Zhang","doi":"10.3760/CMA.J.ISSN.2095-1477.2019.11.011","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.2095-1477.2019.11.011","url":null,"abstract":"Objective \u0000To observe the efficacy of intravitreal ranibizumab injection with panretinal photocoagulation for the treatment of neovascular glaucoma. \u0000 \u0000 \u0000Methods \u0000Total of 20 eyes of 20 cases with neovascular glaucoma in Bayannur Federation of Disabled People’s Eye Hospital from Jan. 2015 to Feb. 2018 were analyzed retrospectively. All cases were treated with intravitreal ranibizumb injection(0.5 mg/0.05 ml)and panretinal photocoagulation at 1 week after injection. \u0000 \u0000 \u0000Results \u0000The IOP was(19.45±8.54)mmHg(1mmHg=0.133 kPa)at 3 months after treatment, which was significantly lower than that before treatment(41.80±9.84)mmHg(P=0.000). The visual acuity was improved significantly (P=0.000). The new vessels of iris and anterior chamber angle basically disappeared. There was no serious complication or adverse reactions in all patients. \u0000 \u0000 \u0000Conclusion \u0000Intravitreal ranibizunmb injection combined with panretinal photocoagulation for the treatment of neovascular glaucoma can significantly reduce the IOP and improve visual function of the patients without obvious adverse reactions. \u0000 \u0000 \u0000Key words: \u0000Glaucoma, neovascular; Ranibizumab; Injection, intravitreal; Photocoagulation, panretinal","PeriodicalId":10126,"journal":{"name":"Chinese Journal of Ocular Trauma and Occupational Eye Disease","volume":"103 1","pages":"853-856"},"PeriodicalIF":0.0,"publicationDate":"2019-11-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77846177","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：